Serotonin and Antiserotonins
- 1 August 1957
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 16 (2) , 246-255
- https://doi.org/10.1161/01.cir.16.2.246
Abstract
Serotonin, (5 hydroxy-tryptamine), a naturally occurring compound, is pharmacologically active on intravenous injection in man. It consistently increases the pulse rate but has a variable pressor depressor, or biphasic effect on the arterial pressure. The mode of action of serotonin on these functions is not clear. Serotonin consistently and characteristically increases ventilation. However, it does not cause striking circulatory changes in the kidney although it usually produces moderate antidiuresis. The benzyl analog of serotonin (BAS) (1-benzyl-2-methyl-3-methoxy-tryptamine), both intravenously and orally, reduces or prevents the symptoms caused by serotonin. Intravenously, BAS in addition has demonstrable "antiserotonin" effects on the characteristic blood pressure and respiratory responses to serotonin.Keywords
This publication has 6 references indexed in Scilit:
- A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma)The American Journal of Medicine, 1956
- Serotonin Release as a Possible Mechanism of Reserpine ActionScience, 1955
- THE EFFECTS OF MITRAL VALVULOPLASTY ON CARDIOVASCULAR AND RENAL FUNCTION AT REST AND DURING EXERCISE 1Journal of Clinical Investigation, 1955
- Serotonin (5-Hydroxytryptamine)Physiological Reviews, 1954
- Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, broncho-constriction, and an unusual type of cyanosisAmerican Heart Journal, 1954
- PHARMACOLOGY OF INDOLEALKYLAMINES1954